S-Ibuprofen Topical Gel 5% (AP0302)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-Ibuprofen Topical Gel 5% (AP0302), covering 2022-01-25 to 2022-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS [Phase 2]